Tania Wrobel Folescu
Overview
Explore the profile of Tania Wrobel Folescu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cohen R, Sztajnbok F, de Marca E, Capelozzi V, Horovitz D, Nunez E, et al.
Pediatr Pulmonol
. 2024 Oct;
60(1):e27339.
PMID: 39412421
No abstract available.
2.
Meyer V, Siqueira M, Costa P, Caetano B, Oliveira Lopes J, Folescu T, et al.
PLoS One
. 2020 Oct;
15(10):e0240452.
PMID: 33112873
Backgrounds: Cystic Fibrosis (CF) is a genetic, multisystemic, progressive illness that causes chronic suppurative lung disease. A major cause of morbimortality in this condition are pulmonary exacerbations. Although classically attributed...
3.
Cohen R, Folescu T, Boechat M, Fonseca V, Marques E, Leao R
Clinics (Sao Paulo)
. 2019 Oct;
74:e1399.
PMID: 31644663
Objective: High-resolution computed tomography (HRCT) allows the early detection of pathological changes in the lung structure, and reproducible scoring systems can be used to quantify chest computed tomography (CT) findings...
4.
Cohen R, Folescu T, Daltro P, Boechat M, Lima D, Marques E, et al.
Sao Paulo Med J
. 2017 Aug;
135(5):420-427.
PMID: 28832807
Context And Objective: The prevalence of a variety of potentially pathogenic microorganisms in cystic fibrosis patients, such as methicillin-resistant Staphylococcus aureus (MRSA), has increased over the past decade. Given the...
5.
da Costa Ferreira Leite C, Folescu T, De Cassia Firmida M, Cohen R, Leao R, de Freitas F, et al.
BMC Pulm Med
. 2017 Jul;
17(1):100.
PMID: 28705217
Background: Burkholderia cepacia complex is a group of opportunistic pathogens in cystic fibrosis (CF) patients believed to be associated with poor prognosis and patient-to-patient transmissibility. Little is known about clinical...
6.
Firmida M, Marques E, Leao R, Pereira R, Rodrigues E, Albano R, et al.
Respir Med Case Rep
. 2017 Feb;
20:98-103.
PMID: 28138423
Introduction: The clinical relevance of infection in cystic fibrosis (CF) remains controversial. This emerging agent in CF has been associated with increased lung inflammation, more frequent exacerbations and more severe...
7.
Folescu T, Costa C, Cohen R, da Conceicao Neto O, Albano R, Marques E
BMC Pulm Med
. 2015 Dec;
15:158.
PMID: 26642758
Background: Pulmonary deterioration after B.cepacia complex (BCC) colonization has a heterogeneous pattern. The aim was to investigate the clinical outcome of BCC colonization in CF patients chronically colonized with P....
8.
Ferreira A, Leao R, DAlincourt Carvalho-Assef A, Dos Santos Ribeiro da Silva E, De Cassia Firmida M, Folescu T, et al.
APMIS
. 2015 Nov;
123(12):1061-8.
PMID: 26522829
A prospective study was conducted in Brazil to evaluate antimicrobial resistance patterns and molecular epidemiology of Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients with chronic lung infection. All isolates...
9.
Martins R, Fonseca A, Acosta F, Folescu T, Higa L, Sad I, et al.
BMC Res Notes
. 2014 Sep;
7:583.
PMID: 25176415
Background: Over 1900 mutations have been identified in the cystic fibrosis conductance transmembrane regulator gene, including single nucleotide substitutions, insertions, and deletions. Unidentified mutations may still lie in introns or...
10.
Candido P, de Souza Nunes L, Marques E, Folescu T, Coelho F, Calado Nogueira de Moura V, et al.
J Clin Microbiol
. 2014 Jun;
52(8):2990-7.
PMID: 24920766
Worldwide, nontuberculous mycobacteria (NTM) have become emergent pathogens of pulmonary infections in cystic fibrosis (CF) patients, with an estimated prevalence ranging from 5 to 20%. This work investigated the presence...